Cognex Corporation
CGNX
$32.09
$0.531.68%
| Weiss Ratings | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Weak | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.44 | |||
| Price History | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.96% | |||
| 30-Day Total Return | -20.34% | |||
| 60-Day Total Return | -14.49% | |||
| 90-Day Total Return | -16.85% | |||
| Year to Date Total Return | -9.90% | |||
| 1-Year Total Return | -21.09% | |||
| 2-Year Total Return | -33.23% | |||
| 3-Year Total Return | -50.67% | |||
| 5-Year Total Return | -24.04% | |||
| 52-Week High % Change | -39.60% | |||
| 52-Week Low % Change | 3.32% | |||
| Price | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $53.13 | |||
| 52-Week Low Price | $31.06 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Jul 16, 2024 | |||
| Valuation | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.45B | |||
| Enterprise Value | 5.28B | |||
| Price/Earnings (TTM) | 52.14 | |||
| Earnings Per Share (TTM) | 0.62 | |||
| Earnings Per Share Growth | -4.97% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 6.05 | |||
| Price/Book (Q) | 3.60 | |||
| Enterprise Value/Revenue (TTM) | 5.77 | |||
| Price | $32.09 | |||
| Enterprise Value/EBITDA (TTM) | 35.39 | |||
| Enterprise Value/EBIT | 45.33 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 172.51M | |||
| Dividend Yield | 0.97% | |||
| Div. Per Share (Most Recent) | $0.08 | |||
| Dividend Per Share (TTM) | $0.31 | |||
| Payout Ratio (TTM) | 49.29% | |||
| Dividend Per Share (Most Recent) | $0.08 | |||
| Company Info | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 508 650 3000 | |||
| Address | One Vision Drive Natick, MA 01760-2059 | |||
| Website | www.cognex.com | |||
| Country | United States | |||
| Year Founded | 1981 | |||
| Profitability | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 12.72% | |||
| Profit Margin | 11.60% | |||
| Management Effectiveness | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.63% | |||
| Return on Equity | 7.03% | |||
| Income Statement | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 914.52M | |||
| Total Revenue (TTM) | 914.52M | |||
| Revenue Per Share | $5.30 | |||
| Gross Profit (TTM) | 625.79M | |||
| EBITDA (TTM) | 149.05M | |||
| EBIT (TTM) | 116.37M | |||
| Net Income (TTM) | 106.17M | |||
| Net Income Avl. to Common (TTM) | 106.17M | |||
| Total Revenue Growth (Q YOY) | 16.79% | |||
| Earnings Growth (Q YOY) | 152.44% | |||
| EPS Diluted (TTM) | 0.62 | |||
| EPS Diluted Growth (Q YOY) | 178.62% | |||
| Balance Sheet | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 246.05M | |||
| Cash Per Share (Q) | $1.43 | |||
| Total Current Assets (Q) | 613.37M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.52B | |||
| Current Ratio (Q) | 3.621 | |||
| Book Value Per Share (Q) | $8.90 | |||
| Total Assets (Q) | 1.99B | |||
| Total Current Liabilities (Q) | 169.38M | |||
| Total Debt (Q) | 70.22M | |||
| Total Liabilities (Q) | 475.35M | |||
| Total Common Equity (Q) | 1.52B | |||
| Cash Flow | CGNX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -38.97M | |||
| Cash from Financing (TTM) | -118.42M | |||
| Net Change in Cash (TTM) | -16.56M | |||
| Levered Free Cash Flow (TTM) | 140.72M | |||
| Cash from Operations (TTM) | 149.08M | |||
